Jamie Arambulo, - Medicare Occupational Therapist in Accokeek, MD

Jamie Arambulo, is a medicare enrolled "Occupational Therapist" provider in Accokeek, Maryland. Her current practice location is 14010 Vintage Ln, Accokeek, Maryland. You can reach out to her office (for appointments etc.) via phone at (240) 381-4816.

Jamie Arambulo is licensed to practice in Virginia (license number 0119006021) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1821402777.

Contact Information

Jamie Arambulo,
14010 Vintage Ln,
Accokeek, MD 20607-3779
(240) 381-4816
Not Available



Healthcare Provider's Profile

Full NameJamie Arambulo
GenderFemale
Speciality
Experience Years
Location14010 Vintage Ln, Accokeek, Maryland
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jamie Arambulo attended and graduated from in
  NPI Data:
  • NPI Number: 1821402777
  • Provider Enumeration Date: 06/18/2014
  • Last Update Date: 06/18/2014
  Medicare PECOS Information:
  • PECOS PAC ID:
  • Enrollment ID:

Medical Identifiers

Medical identifiers for Jamie Arambulo such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1821402777NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225X00000XOccupational Therapist 0119006021 (Virginia)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jamie Arambulo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jamie Arambulo,
14010 Vintage Ln,
Accokeek, MD 20607-3779

Ph: (240) 381-4816
Jamie Arambulo,
14010 Vintage Ln,
Accokeek, MD 20607-3779

Ph: (240) 381-4816

News Archive

The ‘new normal' in post-COVID-19 dental practice

A new paper published in the British Dental Journal in May 2020 reports on the new ways of partnership between the dental industry and dental professionals, in view of the extremely high risk of aerosol production during dental procedures, to reduce the risk of passing on COVID-19 infection.

Aria's non-invasive test more effective in detecting Trisomy 18 & 21

Aria Diagnostics, a molecular diagnostics company, today announced publication of data supporting a directed, non-invasive approach to cell-free DNA (cfDNA) analysis in maternal blood for evaluation of two common fetal trisomies linked to genetic disorders.

PROVENGE receives FDA approval for treatment of CRPC

Dendreon Corporation today announced that the U.S. Food and Drug Administration has approved PROVENGE (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer.

Single prenatal dose of methamphetamine enough to cause long-term neurodevelopmental problems in babies

In research published in the August issue of Free Radical Biology and Medicine, U of T pharmacy and pharmacology professor Peter Wells and his colleagues determined that exposing pregnant mice only once to methamphetamine led to delivery of offspring with long-term neurodevelopmental problems, including reduced motor co-ordination.

Watson Laboratories files ANDA for generic Aplenzin ER in treatment of major depressive disorder

Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.

Read more News

› Verified 9 days ago


Occupational Therapist in Accokeek, MD

Marcia Marie Rosebrock, OTR/L
Occupational Therapist
Medicare: Medicare Enrolled
Practice Location: 2640 Saint Marys View Rd, Accokeek, MD 20607
Phone: 419-487-1590    
Teresa Whigham, MS, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 2206 Green Ginger Circle, Accokeek, MD 20607
Phone: 301-452-4051    
Erika Haley, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 14507 Saint Gregory Way, Accokeek, MD 20607
Phone: 301-882-8511    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.